The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
Their warning depends on whether negotiations for a post-Brexit Britain do not offer freedom of movement for people, capital and goods.
The ex girlfriend of Ben Butler, who was jailed for murdering his daughter Ellie, has spoken of the abuse she suffered with him.
Queen Charlotte's and Chelsea Hospital takes Finnish inspiration to give parents baby boxes, credited with reducing infant mortality rates.